Compare Core and Main Inc (CNM) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Core and Main Inc vs Tenet Healthcare Corporation — how do they compare? Core and Main Inc trades at $46.18 (market cap $8.73B), while Tenet Healthcare Corporation trades at $267.21 (market cap $20.89B). The key difference: Tenet Healthcare Corporation is far larger — about 2.4× Core and Main Inc's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Core and Main Inc nearer its low. Which is the better fit depends on your goals.
| CNM | THC | |
|---|---|---|
Market Cap | $8.73B | $20.89B |
Sector | Technology | Health |
52-Week High | $66.98 | $262.63 |
52-Week Low | $42.37 | $161.37 |
Enterprise Value | $11.02B | $31.97B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Core & Main (CNM) trades at $46.06, down 0.52% on the day, with a bullish technical signal despite mixed moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.57 exceeding expectations. Financials show solid profitability with a 5.87% net income margin and 23.73% ROE, though debt levels remain elevated. Recent news includes institutional position adjustments and a $750 million senior notes offering priced in June 2026.
Outlook is cautiously optimistic with analyst consensus favoring Buy ratings (57%). Key opportunities include margin expansion and municipal strength, while risks involve high debt, competitive pressures, and reliance on infrastructure spending. The stock's valuation at a P/E of 19.76 appears reasonable given growth prospects, but investors should monitor execution against FY26 revenue guidance of $7.8–7.9 billion.
Tenet Healthcare (THC) trades at $266.79, up 2.64% today, with strong technical momentum indicated by a golden cross and bullish moving averages. The stock shows robust fundamentals with a P/E of 10.03, net income margin of 9.9%, and consistent earnings beats in recent quarters. Recent news highlights Zacks' Strong Buy rating and positive Q2 2026 results, with revenue growth and raised 2026 outlook driving investor optimism.
The outlook remains positive given analyst consensus of a $281.44 price target and 81% buy ratings, though risks include policy headwinds and net cash outflows. Earnings growth and ambulatory segment strength present opportunities, but investors should monitor expense management and regulatory changes that could impact margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Core and Main Inc
Core & Main is a leading US distributor of water, wastewater, storm drainage, and fire protection products. It provides essential infrastructure solutions to municipalities, private water companies, and contractors.
Read more on CNM →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
